Literature DB >> 2168701

Characterization of the soluble leukotriene B4 receptor from sheep lung membranes.

B Votta1, J Keefer, S Mong.   

Abstract

Leukotriene B4 (LTB4) is an arachidonate metabolite which elicits a variety of pro-inflammatory responses by activation of a guanine-nucleotide-binding protein-coupled membrane receptor. As a prelude to receptor isolation and purification, we have established assay methods for LTB4 receptor solubilization and characterization from sheep lung membranes. [3H]LTB4 binding to the soluble receptor was saturable, specific, protein-concentration- and time-dependent and reversible. Binding of [3H]LTB4 was enhanced by divalent cations and inhibited by sodium ions in a manner analogous to its binding to the human leukocyte membrane receptor. Saturation binding yielded a dissociation constant (Kd) of 0.50 +/- 0.05 nM and a receptor density (Bmax) of 330 +/- 90 fmol/mg of protein for [3H]LTB4 binding to detergent-solubilized receptor. In competition experiments, the rank order of binding affinity was LTB4 greater than 20-OH-LTB4 greater than trans-homo-LTB4 greater than 6-trans-LTB4 greater than U-75302. Gel-filtration chromatography showed that the LTB4 receptor protein in the detergent micellar state has a molecular mass in the range 800-1000 kDa. These results demonstrate that the physiologically and pharmacologically important LTB4 receptor may be readily solubilized from sheep lung membranes without alteration in binding specificity and characteristics, suggesting that sheep lung membranes represent a rich source with which to pursue receptor isolation and purification.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168701      PMCID: PMC1131700          DOI: 10.1042/bj2700213

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  [3H]leukotriene B4 binding to the guinea-pig spleen membrane preparation: a rich tissue source for a high-affinity leukotriene B4 receptor site.

Authors:  J B Cheng; E I Cheng; F Kohi; R G Townley
Journal:  J Pharmacol Exp Ther       Date:  1986-01       Impact factor: 4.030

Review 3.  Leukotrienes: their formation and role as inflammatory mediators.

Authors:  A W Ford-Hutchinson
Journal:  Fed Proc       Date:  1985-01

4.  Detergent solubilization of human neutrophil leukotriene B4 receptors.

Authors:  A H Lin; P L Ruppel; R R Gorman
Journal:  Biochem Biophys Res Commun       Date:  1985-04-30       Impact factor: 3.575

5.  Structural requirements for chemotactic activity of leukotriene B4 (LTB4).

Authors:  S T Hoffstein; R M Manzi; K A Razgaitis; P E Bender; J Gleason
Journal:  Prostaglandins       Date:  1986-02

6.  Leukotriene B4 induces formation of inositol phosphates in rat peritoneal polymorphonuclear leukocytes.

Authors:  S Mong; G Chi-Rosso; J Miller; K Hoffman; K A Razgaitis; P Bender; S T Crooke
Journal:  Mol Pharmacol       Date:  1986-09       Impact factor: 4.436

7.  Selective transduction of human polymorphonuclear leukocyte functions by subsets of receptors for leukotriene B4.

Authors:  D W Goldman; E J Goetzl
Journal:  J Allergy Clin Immunol       Date:  1984-09       Impact factor: 10.793

8.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.

Authors:  B Samuelsson
Journal:  Science       Date:  1983-05-06       Impact factor: 47.728

9.  Pertussis toxin inhibition of chemotactic factor-induced calcium mobilization and function in human polymorphonuclear leukocytes.

Authors:  D W Goldman; F H Chang; L A Gifford; E J Goetzl; H R Bourne
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

10.  Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chemotactic response.

Authors:  D W Goldman; E J Goetzl
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.